ELISABETH ELLIOTT: Open Payments
NPI 1508627589 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,783 in 113 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $753 · 2025 $2,783
Food & beverage: $2,698Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $411 |
| UCB, Inc. | 10 | $393 |
| Organon LLC | 15 | $304 |
| Regeneron Healthcare Solutions, Inc. | 5 | $272 |
| Incyte Corporation | 17 | $265 |
| Lilly USA, LLC | 8 | $219 |
| Janssen Biotech, Inc. | 10 | $183 |
| GENZYME CORPORATION | 3 | $113 |
| PFIZER INC. | 4 | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $106 |
Products named: Bimzelx, DUPIXENT, OPZELURA, TREMFYA, SKYRIZI, VTAMA, EBGLYSS, CIBINQO.
Industry payments across CA — which companies pay providers there.
